Novartis | 营业费用

Operating Expenses 更改 日
AstraZeneca USD 9.54B 578M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Prestige Brands USD 195.91M 2.16M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Supernus Pharmaceuticals USD 165.31M 19.57M 2023-12



Novartis 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.